District of Columbia Amendment No. 2 to Registration Rights Agreement between Visible Genetics, Inc. and purchasers of common shares of the company

• Category: Corporations - Public - Rights
• State: Multi-State
• Control #: US-EG-9138
• Format: Word; Rich Text

Description

Amendment No. 2 to Registration Rights Agreement between Turnstone Systems, Inc. and purchaser dated January 12, 1998. 4 pages District of Columbia Amendment No. 2 to the Registration Rights Agreement between Visible Genetics, Inc. and the purchasers of common shares of the company is a legal document that outlines modifications made to the original agreement regarding the registration rights of common shares within the District of Columbia jurisdiction. Keywords: District of Columbia, Amendment No. 2, Registration Rights Agreement, Visible Genetics, Inc., purchasers, common shares. The primary purpose of the District of Columbia Amendment No. 2 is to update and refine the obligations, rights, and responsibilities of both Visible Genetics, Inc. and the purchasers of common shares. These modifications are specific to the District of Columbia, ensuring compliance with its unique legal requirements. The Amendment includes clarifications and adjustments to the initial agreement, in order to promote transparency, protect the interests of both parties, and maintain compliance with District of Columbia laws and regulations. This document aims to address any gaps, contingencies, or specific issues that were not initially addressed in the original Registration Rights Agreement. Some potential types of District of Columbia Amendment No. 2 to the Registration Rights Agreement may include amendments relating to financial reporting requirements within the District, changes regarding the registration process and timeline, adjustments to disclosure obligations, updates to voting rights or shareholder agreements specific to the District of Columbia, and revisions to any other aspect of the original agreement that need to align with District laws. By issuing such amendments, both Visible Genetics, Inc. and the purchasers of common shares demonstrate their commitment to adhering to the legal framework of the District of Columbia and upholding the necessary regulations governing the registration of common shares within that jurisdiction. It is important to note that the specific content and nature of the District of Columbia Amendment No. 2 may vary depending on the unique circumstances, needs, and agreements between Visible Genetics, Inc. and the purchasers of common shares. Thus, it is always advisable to consult the actual Amendment document for precise details and implications.

District of Columbia Amendment No. 2 to the Registration Rights Agreement between Visible Genetics, Inc. and the purchasers of common shares of the company is a legal document that outlines modifications made to the original agreement regarding the registration rights of common shares within the District of Columbia jurisdiction. Keywords: District of Columbia, Amendment No. 2, Registration Rights Agreement, Visible Genetics, Inc., purchasers, common shares. The primary purpose of the District of Columbia Amendment No. 2 is to update and refine the obligations, rights, and responsibilities of both Visible Genetics, Inc. and the purchasers of common shares. These modifications are specific to the District of Columbia, ensuring compliance with its unique legal requirements. The Amendment includes clarifications and adjustments to the initial agreement, in order to promote transparency, protect the interests of both parties, and maintain compliance with District of Columbia laws and regulations. This document aims to address any gaps, contingencies, or specific issues that were not initially addressed in the original Registration Rights Agreement. Some potential types of District of Columbia Amendment No. 2 to the Registration Rights Agreement may include amendments relating to financial reporting requirements within the District, changes regarding the registration process and timeline, adjustments to disclosure obligations, updates to voting rights or shareholder agreements specific to the District of Columbia, and revisions to any other aspect of the original agreement that need to align with District laws. By issuing such amendments, both Visible Genetics, Inc. and the purchasers of common shares demonstrate their commitment to adhering to the legal framework of the District of Columbia and upholding the necessary regulations governing the registration of common shares within that jurisdiction. It is important to note that the specific content and nature of the District of Columbia Amendment No. 2 may vary depending on the unique circumstances, needs, and agreements between Visible Genetics, Inc. and the purchasers of common shares. Thus, it is always advisable to consult the actual Amendment document for precise details and implications.